American Funds®

GROWTH FUNDS

®

471 Total Holdings:
As of 12/31/14 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 471
Asset Type
Novo Nordisk A/S, Class B Equity 109,943,184 $4,651,872,274.00 3.85%
Bayer AG Equity 21,038,384 $2,876,144,785.00 2.38%
Novartis AG Equity 28,651,405 $2,634,997,634.00 2.18%
SoftBank Corp. Equity 39,802,600 $2,368,741,712.00 1.96%
Prudential PLC Equity 93,463,984 $2,150,806,424.00 1.78%
Associated British Foods PLC Equity 38,705,838 $1,880,547,360.00 1.56%
Barclays PLC Equity 494,649,410 $1,859,634,955.00 1.54%
Baidu, Inc., Class A (ADR) Equity 7,780,900 $1,773,811,773.00 1.47%
British American Tobacco PLC Equity 26,840,999 $1,458,374,337.00 1.21%
HDFC Bank Ltd. Equity 93,649,732 $1,404,437,822.00 1.16%
Toyota Motor Corp. Equity 22,046,000 $1,374,801,062.00 1.14%
Murata Manufacturing Co., Ltd. Equity 12,465,600 $1,361,661,338.00 1.13%
Taiwan Semiconductor Manufacturing Co., Ltd. Equity 302,957,649 $1,336,870,513.00 1.11%
AIA Group Ltd. Equity 225,761,200 $1,243,145,280.00 1.03%
Ryanair Holdings PLC (ADR) Equity 16,602,989 $1,183,295,026.00 0.98%
All Holdings: 1 - 15 of 471

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

  1. Excludes certain securities in initial period of acquisition.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.